There is no current national screening programme for prostate cancer; the committee that decides these things is looking into ...

Prostate cancer is the malignant growth of cells in the prostate, a walnut-sized gland below the bladder, that is responsible ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital, and four other institutions ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

The prostate health index (PHI) is a newer blood test that more accurately assesses your risk of prostate cancer than the ...

More than one million American men may have been unnecessarily diagnosed and treated for prostate cancer since widespread use of the prostate-specific antigen (PSA) blood test began in 1987, a new ...

Dr. Paul Gellhaus says PSA testing and modern biopsy methods ease fears and reassure patients, making early prostate cancer ...

The test, supported partly by funding from the National Institutes of Health, leverages biomarkers found in urine to detect ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO-End Prostate Cancer, about ...

For decades, it has been known that prostate specific antigen ‒ or PSA ‒ tests are a flawed way to diagnose prostate cancer. Many men have a high PSA without having cancer. Others have low PSA that ...

Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...

The Korean Society of Oncology (Chairman Jung Byung-chang) held a press conference at the Korea Press Center and emphasized the rapidly increasing status of prostate cancer in the elderly and the need ...